Gurgone Danila, McShane Lucy, McSharry Charles, Guzik Tomasz J, Maffia Pasquale
Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Department of Pharmacy, University of Naples Federico II, Naples, Italy.
Front Pharmacol. 2020 Mar 4;11:166. doi: 10.3389/fphar.2020.00166. eCollection 2020.
Cardiovascular disease (CVD) is an important comorbidity in a number of chronic inflammatory diseases. However, evidence in highly prevalent respiratory disease such as asthma are still limited. Epidemiological and clinical data are not univocal in supporting the hypothesis that asthma and CVD are linked and the mechanisms of this relationship remain poorly defined. In this review, we explore the relationship between asthma and cardiovascular disease, with a specific focus on cytokine contribution to vascular dysfunction and atherosclerosis. This is important in the context of recent evidence linking broad inflammatory signaling to cardiovascular events. However inflammatory regulation in asthma is different to the one typically observed in atherosclerosis. We focus on the contribution of cytokine networks encompassing IL-4, IL-6, IL-9, IL-17A, IL-33 but also IFN-γ and TNF-α to vascular dysfunction in atherosclerosis. In doing so we highlight areas of unmet need and possible therapeutic implications.
心血管疾病(CVD)是许多慢性炎症性疾病中的一种重要合并症。然而,在哮喘等高度流行的呼吸系统疾病方面的证据仍然有限。流行病学和临床数据在支持哮喘与心血管疾病相关这一假说方面并不一致,且这种关系的机制仍不清楚。在本综述中,我们探讨哮喘与心血管疾病之间的关系,特别关注细胞因子对血管功能障碍和动脉粥样硬化的作用。鉴于最近有证据表明广泛的炎症信号与心血管事件有关,这一点很重要。然而,哮喘中的炎症调节与动脉粥样硬化中通常观察到的情况不同。我们关注包括白细胞介素-4、白细胞介素-6、白细胞介素-9、白细胞介素-17A、白细胞介素-33以及干扰素-γ和肿瘤坏死因子-α在内的细胞因子网络对动脉粥样硬化中血管功能障碍的作用。在此过程中,我们强调了未满足的需求领域以及可能的治疗意义。